Royal Bank of Canada’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,518
| Closed | -$272K | – | 8265 |
|
|
2021
Q3 | $272K | Sell |
15,518
-41,464
| -73% | -$484K | ﹤0.01% | 4886 |
|
|
2021
Q2 | $552K | Sell |
56,982
-80,819
| -59% | -$761K | ﹤0.01% | 4179 |
|
|
2021
Q1 | $1.48M | Sell |
137,801
-32,722
| -19% | -$405K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $2.51M | Buy |
170,523
+169,063
| +11,580% | +$2.44M | ﹤0.01% | 2716 |
|
|
2020
Q3 | $21K | Buy |
1,460
+366
| +33% | +$3.65K | ﹤0.01% | 5690 |
|
|
2020
Q2 | $9K | Sell |
1,094
-2,737
| -71% | -$16.9K | ﹤0.01% | 5886 |
|
|
2020
Q1 | $15K | Buy |
3,831
+3,104
| +427% | +$11.7K | ﹤0.01% | 5685 |
|
|
2019
Q4 | $1K | Sell |
727
-880
| -55% | -$337 | ﹤0.01% | 6739 |
|
|
2019
Q3 | $0 | Buy |
1,607
+997
| +163% | +$337 | ﹤0.01% | 7336 |
|
|
2019
Q2 | $0 | Sell |
610
-10,852
| -95% | -$5.59K | ﹤0.01% | 7342 |
|
|
2019
Q1 | $8K | Buy |
11,462
+10,852
| +1,779% | +$13.3K | ﹤0.01% | 6114 |
|
|
2018
Q4 | $1K | Hold |
610
| – | – | ﹤0.01% | 6646 |
|
|
2018
Q3 | $4K | Hold |
610
| – | – | ﹤0.01% | 6374 |
|
|
2018
Q2 | $4K | Sell |
610
-587
| -49% | -$3.74K | ﹤0.01% | 6123 |
|
|
2018
Q1 | $9K | Buy |
1,197
+587
| +96% | +$4.45K | ﹤0.01% | 5771 |
|
|
2017
Q4 | $4K | Sell |
610
-288
| -32% | -$2.38K | ﹤0.01% | 6157 |
|
|
2017
Q3 | $5K | Buy |
898
+288
| +47% | +$1.35K | ﹤0.01% | 6436 |
|
|
2017
Q2 | $3K | Sell |
610
-1,474
| -71% | -$8.15K | ﹤0.01% | 6215 |
|
|
2017
Q1 | $13K | Buy |
2,084
+1,507
| +261% | +$8.83K | ﹤0.01% | 5849 |
|
|
2016
Q4 | $3K | Buy |
577
+317
| +122% | +$3.16K | ﹤0.01% | 6432 |
|
|
2016
Q3 | $4K | Buy |
260
+154
| +145% | +$1.77K | ﹤0.01% | 6047 |
|
|
2016
Q2 | $1K | Sell |
106
-37
| -26% | -$385 | ﹤0.01% | 6291 |
|
|
2016
Q1 | $1K | Sell |
143
-82
| -36% | -$691 | ﹤0.01% | 6260 |
|
|
2015
Q4 | $3K | Buy |
225
+186
| +477% | +$2.59K | ﹤0.01% | 6306 |
|
|
2015
Q3 | $1K | Hold |
39
| – | – | ﹤0.01% | 6540 |
|
|
2015
Q2 | $1K | Hold |
39
| – | – | ﹤0.01% | 6495 |
|
|
2015
Q1 | $1K | Hold |
39
| – | – | ﹤0.01% | 6018 |
|
|
2014
Q4 | $0 | Buy |
+39
| New | +$305 | ﹤0.01% | 6361 |
|
Other funds holding TRIL
Royal Bank of Canada's TRIL Position: Q4 2021 in Review
Royal Bank of Canada sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 15,518 shares — an estimated $272K sold.
Royal Bank of Canada first reported a position in TRIL in Q4 2014 and held it in 28 quarters. The position peaked at $2.51M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.
- Royal Bank of Canada reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
- Royal Bank of Canada sold 15,518 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $272K.
- Royal Bank of Canada first reported a position in Trillium Therapeutics Inc. in Q4 2014 and held it in 28 quarters.
- Royal Bank of Canada's Trillium Therapeutics Inc. position peaked at $2.51M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.
Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.